COMMUNIQUÉS West-GlobeNewswire

AGTC to Present at Upcoming Conferences
28/08/2019
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Sunesis Pharmaceuticals to Present at the Wells Fargo Healthcare Conference
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Willie Quinn, Chief Financial Officer and Senior Vice President of Finance and Corporate [...]
Emerald Health Therapeutics Announces $25 Million Convertible Debenture Unit Financing
28/08/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “ [...]
Emerald Health Therapeutics to Present at Rodman & Renshaw 21st Annual Global Investment Conference
28/08/2019
VANCOUVER, British Columbia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that it will present a corporate overview and be available for 1x1 [...]
Emerald Health Therapeutics fera une présentation lors de la 21e conférence mondiale annuelle sur les investissements de Rodman & Renshaw
28/08/2019
VANCOUVER, Colombie-Britannique, 28 août 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) a annoncé aujourd'hui qu'elle présentera un aperçu de l'entreprise et sera [...]
Medtronic Announces Planned Leadership Succession
28/08/2019
Omar Ishrak Will Retire as CEO at End of Fiscal Year; Remains Chairman of the Board and Becomes Executive Chairman of Medtronic Geoff Martha, EVP of the Restorative Therapies Group, Appointed Medtronic President, and [...]
Teleflex to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
28/08/2019
WAYNE, Pa., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 17 th Annual Global Healthcare Conference at the Grand Hyatt in [...]
Precision BioSciences to Present at Upcoming Investor Conferences
28/08/2019
DURHAM, N.C., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life through the application of its pioneering, proprietary ARCUS [...]
Exactus Inc. Provides Hemp Farm Update and Will Begin Taking Orders for Triple A Top Flower
28/08/2019
DELRAY BEACH, Fla., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI) (the “Company”), a farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it is on track to exceed its [...]
Amarin to Participate in the H.C. Wainwright 21st Annual Global Investment Conference
28/08/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
28/08/2019
This is an unofficial in-house translation of the Swedish original. In case of differences the Swedish version shall prevail. The shareholders of Oasmia Pharmaceutical AB are hereby given notice of the Annual General [...]
TLC to Present at Upcoming Investor Conferences in September 2019
28/08/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 28, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152) today announced that the management team is scheduled to present at the two upcoming investor conferences: [...]
Correction: Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
28/08/2019
Company announcement – No. 27 / 2019 Copenhagen, August 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development [...]
Affimed to Participate in Investor Conferences in September
28/08/2019
Heidelberg, Germany, August 28, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability to fight cancer, today announced its participation in [...]
LIDDS: Liproca® Depot Phase IIb results to be presented as “Late Breaking News” at EMUC in Vienna on November 16, 2019
28/08/2019
Professor Laurence Klotz, a world leading expert in Active Surveillance of prostate cancer patients, will present the results of the LPC-004 prostate cancer study at the 11th European Multidisciplinary Congress on [...]
Olainfarm invites to Second Quarter 2019 Investor Conference Webinar
28/08/2019
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 3, 2019 at 16:00 (EEST). To join the webinar please follow [...]
Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited)
28/08/2019
Herantis Pharma Plc Company release August 28, 2019 at 9:00am Herantis Pharma Plc announces half year financial report January 1 - June 30, 2019 (unaudited) Randomized clinical studies in Parkinson’s and lymphedema [...]
Zealand Pharma appoints Matthew Dallas as new Chief Financial Officer
28/08/2019
Company announcement – No. 27 / 2019 Copenhagen, August 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development [...]
Orphazyme announces Interim Report First Half 2019
28/08/2019
Company announcement Orphazyme A/S No. 26/2019 Company Registration No. 32266355 Copenhagen, Denmark, August 28, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments [...]

Pages